Patent Assignment
Reel/Frame 037467/0854
Assignment of Assignor's Interest
Recorded: 2016-01-12
Pages: 3
Assignor
BAUM, MARK L.
Executed: 2015-12-29
Assignee
IMPRIMIS PHARMACEUTICALS, INC.
12264 EL CAMINO REAL, STE. 350, SAN DIEGO, CALIFORNIA, 92121
Covered Property
(1)
Pharmaceutical Formulations of Xanthine or Xanthine Derivatives
Application:
14/982,322 →
Publication:
US 2016/0193213
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Intellectual Property Security Agreement
Jul 19, 2017
From: IMPRIMIS PHARMACEUTICALS, INC.
To: SWK FUNDING LLC, AS COLLATERAL AGENT
Reel/Frame 043258/0581 →
Assignment of Assignor's Interest
Aug 18, 2017
From: IMPRIMIS PHARMACEUTICALS, INC.
To: ETON PHARMACEUTICALS, INC.
Reel/Frame 043338/0187 →
Assignment of Assignor's Interest
Jul 13, 2018
From: ETON PHARMACEUTICALS, INC.
To: IMPRIMIS PHARMACEUTICALS, INC.
Reel/Frame 046344/0963 →
Change of Name
Jan 7, 2019
From: IMPRIMIS PHARMACEUTICALS, INC.
To: HARROW HEALTH, INC.
Reel/Frame 048019/0161 →
Assignment of Assignor's Interest
Nov 1, 2019
From: HARROW HEALTH, INC.
To: HARROW IP, LLC
Reel/Frame 050903/0404 →
Release of Security Interest
May 7, 2021
From: SWK FUNDING LLC
To: HARROW IP, LLC
Reel/Frame 056174/0332 →